Amit Sachdev, EVP Chief Patient & Ext Af Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 8,477 shares at $425.70 ($3.6M) on 2024-02-26, disclosed to the SEC on 2024-02-27.
Scheduled sale ($3.6M) by EVP Chief Patient & Ext Af Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $431.79 | 2,469 | $1.1M | 29.4% |
| 2 | $425.70 | 3,004 | $1.3M | 35.3% |
| 3 | $425.70 | 3,004 | $1.3M | 35.3% |
| Total | $427.47 avg | 8,477 | $3.6M | 100% |
| Filing → |
| VRTX | SELL | 2024-05-17 | $14K | — | Filing → |
| VRTX | SELL | 2024-02-23 | $2.7M | — | Filing → |
| VRTX | SELL | 2024-02-21 | $3.6M | — | Filing → |